{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:00:08Z","timestamp":1773327608785,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:00:00Z","timestamp":1702684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:00:00Z","timestamp":1702684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A4A5032806"],"award-info":[{"award-number":["2021R1A4A5032806"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sarcoidosis, an idiopathic and inflammatory disease, affects various organs and can manifest as uveitis. Due to limited evidence, researchers investigated the risk factors associated with uveitis in patients with pulmonary sarcoidosis. A retrospective study was conducted on 71 pulmonary sarcoidosis patients, including 19 with uveitis and 52 without. Data on involved organs, imaging findings, spirometry, and analyses from blood and bronchoalveolar lavage fluid were collected. Logistic regression models were used for multivariate analysis. Among the 71 newly diagnosed pulmonary sarcoidosis patients, uveitis was observed in 19 patients (26.8%). No significant differences were found in clinical characteristics between patients with and without uveitis. Fewer patients with uveitis presented lung parenchymal lesions (<jats:italic>P<\/jats:italic>\u2009=\u20090.043). In multivariate analysis, skin lesions (aOR 7.619, 95% CI 1.277\u201345.472, <jats:italic>P<\/jats:italic>\u2009=\u20090.026) and ophthalmic symptoms (aOR 4.065, 95% CI 1.192\u201313.863, <jats:italic>P<\/jats:italic>\u2009=\u20090.025) were associated with uveitis. Absence of uveitis was related to lung parenchymal lesions (aOR 0.233, 95% CI 0.062\u20130.883, <jats:italic>P<\/jats:italic>\u2009=\u20090.032). Approximately one-quarter of patients with an initial diagnosis of pulmonary sarcoidosis were diagnosed with uveitis. Presence of skin lesions, ophthalmic symptoms, and absence of lung parenchymal lesions were related to uveitis. These results need to be clarified by further studies to confirm the clinical role of early ophthalmologic screening for pulmonary sarcoidosis patients with these factors.<\/jats:p>","DOI":"10.1038\/s41598-023-49894-5","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T06:01:55Z","timestamp":1702706515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical manifestations and associated factors of uveitis in patients with pulmonary sarcoidosis: a case control study"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8226-9585","authenticated-orcid":false,"given":"Jang Ho","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0726-0193","authenticated-orcid":false,"given":"Ye Eun","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2235-9834","authenticated-orcid":false,"given":"Jiyoul","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3154-4858","authenticated-orcid":false,"given":"Ho Cheol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5887-8033","authenticated-orcid":false,"given":"Junyeop","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,16]]},"reference":[{"key":"49894_CR1","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMra2101555","volume":"385","author":"M Drent","year":"2021","unstructured":"Drent, M., Crouser, E. D. & Grunewald, J. Challenges of sarcoidosis and its management. N. Engl. J. Med. 385, 1018\u20131032 (2021).","journal-title":"N. Engl. J. Med."},{"key":"49894_CR2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.autrev.2014.04.001","volume":"13","author":"Y Jamilloux","year":"2014","unstructured":"Jamilloux, Y., Kodjikian, L., Broussolle, C. & Seve, P. Sarcoidosis and uveitis. Autoimmun. Rev. 13, 840\u2013849 (2014).","journal-title":"Autoimmun. Rev."},{"key":"49894_CR3","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jama.2022.1570","volume":"327","author":"JA Belperio","year":"2022","unstructured":"Belperio, J. A. et al. Diagnosis and treatment of pulmonary sarcoidosis: A review. JAMA 327, 856\u2013867 (2022).","journal-title":"JAMA"},{"key":"49894_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ccm.2015.08.009","volume":"36","author":"S Pasadhika","year":"2015","unstructured":"Pasadhika, S. & Rosenbaum, J. T. Ocular sarcoidosis. Clin Chest Med. 36, 669\u2013683 (2015).","journal-title":"Clin Chest Med."},{"key":"49894_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.mayocpiqo.2019.04.006","volume":"3","author":"P Ungprasert","year":"2019","unstructured":"Ungprasert, P., Ryu, J. H. & Matteson, E. L. Clinical manifestations, diagnosis, and treatment of sarcoidosis. Mayo Clin. Proc. Innov. Qual. Outcomes 3, 358\u2013375 (2019).","journal-title":"Mayo Clin. Proc. Innov. Qual. Outcomes"},{"key":"49894_CR6","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/j.lpm.2012.04.004","volume":"41","author":"B Bodaghi","year":"2012","unstructured":"Bodaghi, B., Touitou, V., Fardeau, C., Chapelon, C. & LeHoang, P. Ocular sarcoidosis. Presse Med. 41, e349-354 (2012).","journal-title":"Presse Med."},{"key":"49894_CR7","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser, E. D. et al. Diagnosis and detection of sarcoidosis. An official American thoracic society clinical practice guideline. Am. J. Respir. Crit. Care Med. 201, e26\u2013e51 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"49894_CR8","doi-asserted-by":"publisher","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","volume":"58","author":"RP Baughman","year":"2021","unstructured":"Baughman, R. P. et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur. Respir. J. 58, 2004079 (2021).","journal-title":"Eur. Respir. J."},{"key":"49894_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/BF00153496","volume":"72","author":"A Rothova","year":"1989","unstructured":"Rothova, A. et al. Risk factors for ocular sarcoidosis. Doc. Ophthalmol Adv. Ophthalmol. 72, 287\u2013296 (1989).","journal-title":"Doc. Ophthalmol Adv. Ophthalmol."},{"key":"49894_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3109\/09273948.2013.775311","volume":"21","author":"G Sungur","year":"2013","unstructured":"Sungur, G., Hazirolan, D. & Bilgin, G. Pattern of ocular findings in patients with biopsy-proven sarcoidosis in Turkey. Ocul. Immunol. Inflamm. 21, 455\u2013461 (2013).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"49894_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ophtha.2006.05.074","volume":"114","author":"M Evans","year":"2007","unstructured":"Evans, M., Sharma, O., LaBree, L., Smith, R. E. & Rao, N. A. Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis. Ophthalmology 114, 325\u2013333 (2007).","journal-title":"Ophthalmology"},{"key":"49894_CR12","first-page":"9308414","volume":"2018","author":"SY Choi","year":"2018","unstructured":"Choi, S. Y., Lee, J. H., Won, J.-Y., Shin, J. A. & Park, Y.-H. Ocular manifestations of biopsy-proven pulmonary sarcoidosis in Korea. J. Ophthalmol. 2018, 9308414 (2018).","journal-title":"J. Ophthalmol."},{"key":"49894_CR13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3109\/09273948.2016.1167224","volume":"25","author":"A Radosavljevi\u0107","year":"2017","unstructured":"Radosavljevi\u0107, A. et al. Clinical features of ocular sarcoidosis in patients with biopsy-proven pulmonary sarcoidosis in Serbia. Ocul. Immunol. Inflammat. 25, 785\u2013789 (2017).","journal-title":"Ocul. Immunol. Inflammat."},{"key":"49894_CR14","first-page":"209","volume":"34","author":"Z Ying","year":"2017","unstructured":"Ying, Z. et al. Clinical characteristics of sarcoidosis patients in the United States versus China. Sarcoidosis Vasc. Diffuse Lung Dis. 34, 209\u2013216 (2017).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"49894_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12890-020-01191-x","volume":"20","author":"HS Te","year":"2020","unstructured":"Te, H. S. et al. Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts. BMC Pulm. Med. 20, 155 (2020).","journal-title":"BMC Pulm. Med."},{"key":"49894_CR16","doi-asserted-by":"publisher","first-page":"1700991","DOI":"10.1183\/13993003.00991-2017","volume":"51","author":"JC Schupp","year":"2018","unstructured":"Schupp, J. C. et al. Phenotypes of organ involvement in sarcoidosis. Eur. Respir. J. 51, 1700991 (2018).","journal-title":"Eur. Respir. J."},{"key":"49894_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000321947","volume":"46","author":"A Heiligenhaus","year":"2011","unstructured":"Heiligenhaus, A., Wefelmeyer, D., Wefelmeyer, E., R\u00f6sel, M. & Schrenk, M. The eye as a common site for the early clinical manifestation of sarcoidosis. Ophthalmic Res. 46, 9\u201312 (2011).","journal-title":"Ophthalmic Res."},{"key":"49894_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10384-004-0154-z","volume":"49","author":"T Matsuo","year":"2005","unstructured":"Matsuo, T., Fujiwara, N. & Nakata, Y. First presenting signs or symptoms of sarcoidosis in a Japanese population. Jpn. J. Ophthalmol. 49, 149\u2013152 (2005).","journal-title":"Jpn. J. Ophthalmol."},{"key":"49894_CR19","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1080\/09273948.2021.1976216","volume":"30","author":"J Lee","year":"2022","unstructured":"Lee, J. et al. The role of screening for asymptomatic ocular inflammation in sarcoidosis. Ocul. Immunol. Inflammat. 30, 1936\u20131939 (2022).","journal-title":"Ocul. Immunol. Inflammat."},{"key":"49894_CR20","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S0954-6111(03)00127-6","volume":"97","author":"H Yanardag","year":"2003","unstructured":"Yanardag, H., Pamuk, O. N. & Karayel, T. Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients. Respir. Med. 97, 978\u2013982 (2003).","journal-title":"Respir. Med."},{"key":"49894_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/09273948.2013.820836","volume":"22","author":"LE Caspers","year":"2014","unstructured":"Caspers, L. E., Ebraert, H., Makhoul, D., Willermain, F. & Michel, O. Broncho-alveolar lavage (BAL) for the diagnosis of sarcoidosic uveitis. Ocul. Immunol. Inflamm. 22, 102\u2013109 (2014).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"49894_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2169\/internalmedicine1962.28.50","volume":"28","author":"M Sugimoto","year":"1989","unstructured":"Sugimoto, M., Nakashima, H., Ando, M., Kohrogi, H. & Araki, S. Bronchoalveolar lavage studies in uveitis patients without radiological intrathoracic involvement of sarcoidosis. Jpn. J. Med. 28, 50\u201354 (1989).","journal-title":"Jpn. J. Med."},{"key":"49894_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1183\/09031936.01.99104501","volume":"18","author":"T Takahashi","year":"2001","unstructured":"Takahashi, T. et al. Significance of lymphocytosis in bronchoalveolar lavage in suspected ocular sarcoidosis. Eur. Respir. J. 18, 515\u2013521 (2001).","journal-title":"Eur. Respir. J."},{"key":"49894_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/03009730802579729","volume":"114","author":"E Danila","year":"2009","unstructured":"Danila, E., Jurgauskiene, L., Norkuniene, J. & Malickaite, R. BAL fluid cells in newly diagnosed pulmonary sarcoidosis with different clinical activity. Upsala J. Med. Sci. 114, 26\u201331 (2009).","journal-title":"Upsala J. Med. Sci."},{"key":"49894_CR25","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1183\/09031936.03.00010403","volume":"21","author":"MW Ziegenhagen","year":"2003","unstructured":"Ziegenhagen, M. W., Rothe, M. E., Schlaak, M. & Muller-Quernheim, J. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur. Respir. J. 21, 407\u2013413 (2003).","journal-title":"Eur. Respir. J."},{"key":"49894_CR26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.4103\/lungindia.lungindia_380_19","volume":"37","author":"S Kobak","year":"2020","unstructured":"Kobak, S. Catch the rainbow: Prognostic factor of sarcoidosis. Lung India 37, 425\u2013432 (2020).","journal-title":"Lung India"},{"key":"49894_CR27","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.rmed.2018.09.008","volume":"144s","author":"BJ Petek","year":"2018","unstructured":"Petek, B. J. et al. Cardiac sarcoidosis: Diagnosis confirmation by bronchoalveolar lavage and lung biopsy. Respir. Med. 144s, S13-s19 (2018).","journal-title":"Respir. Med."},{"key":"49894_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12890-020-1117-y","volume":"20","author":"T Akaba","year":"2020","unstructured":"Akaba, T. et al. Coexistence of diffuse panbronchiolitis and sarcoidosis revealed during splenectomy: A case report. BMC Pulm. Med. 20, 77 (2020).","journal-title":"BMC Pulm. Med."},{"key":"49894_CR29","first-page":"149","volume":"16","author":"GW Hunninghake","year":"1999","unstructured":"Hunninghake, G. W. et al. ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc. Diffuse Lung Dis. 16, 149\u2013173 (1999).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"49894_CR30","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1136\/bjophthalmol-2018-313356","volume":"103","author":"M Mochizuki","year":"2019","unstructured":"Mochizuki, M. et al. Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br. J. Ophthalmol. 103, 1418\u20131422 (2019).","journal-title":"Br. J. Ophthalmol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49894-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49894-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49894-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T06:04:02Z","timestamp":1702706642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49894-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,16]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["49894"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-49894-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,16]]},"assertion":[{"value":"4 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22380"}}